Stockreport

AbbVie Nabs Eye Disease Gene Therapy From Regenxbio for Up to $1.8 Billion [Barron's]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF AbbVie (ticker: ABBV) shares were up 1.7% early Monday, while Regenxbio shares jumped 27%. The companies will develop Regenxbio’s gene therapy... [Read more]